| |
Parameter
|
IRR
|
95% CI
|
p-value
|
|---|
|
All cancer
|
CD4 [per 100 cells/μl]
|
0.66
|
0.57 - 0.76
|
< 0.001
|
| |
HBV co-infection
|
2.15
|
1.10 - 4.20
|
0.024
|
| |
Use of HAART
|
0.28
|
0.19 - 0.41
|
< 0.001
|
| |
Age [per 10 years]
|
1.23
|
1.03 - 1.46
|
0.023
|
|
Infectious related cancer
|
CD4 [per 100 cells/μl]
|
0.54
|
0.46 - 0.65
|
< 0.001
|
| |
HBV co-infection
|
1.99
|
1.02 - 3.90
|
0.045
|
| |
Use of HAART
|
0.24
|
0.16 - 0.37
|
< 0.001
|
| |
Age [per 10 years]
|
1.10
|
0.91 - 1.34
|
0.334
|
|
non-infectious related cancer
|
CD4 [per 100 cells/μl]
|
1.11
|
0.97 - 1.26
|
0.125
|
| |
HBV co-infection
|
3.08
|
0.73 - 13.1
|
0.129
|
| |
Use of HAART
|
0.42
|
0.17 - 1.06
|
0.065
|
| |
Age [per 10 years]
|
1.99
|
1.52 - 2.61
|
< 0.001
|
- adjusted for presumed eligible confounders.
- IRR incidence rate ratio; CI confidence interval
